Yuval Cabilly

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Ramat Hasharon, Israel
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Roy Golan, as attorney-in-fact for the Reporting Person
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Yuval Cabilly

Form 4 holding Director

Ayala Pharmaceuticals, Inc.

Security class
Common Stock, par value $0.001 per share
Shares / value
677,386
Estimated value
$270,954
Report date
18 Oct 2023
Price
$0.4000
Ownership
Indirect

Insider Reports Filed by Yuval Cabilly

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .